These results are consistent with our current study in which C2 IgM mAb induced inflammation but scFV-linked Crry with C2 reduced inflammation, i.e., arthritis probably by targeting to apoptotic sFLS in the knee joints. Here, CD40LG is linked to arthritic joint disease.